Q1 2023 Holdings
Filed 2023-05-15 | 32 holdings | $656.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $66.0M | 1,845,000 | 10.1% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $55.7M | 2,189,659 | 8.5% |
| Merus N V | COM | N5749R100 | $54.3M | 2,950,000 | 8.3% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $51.5M | 4,772,421 | 7.8% |
| Bellus Health Inc New(BLU) | COM NEW | 07987C204 | $47.4M | 6,579,359 | 7.2% |
| Ambrx Biopharma Inc | SPONSORED ADS | 02290A102 | $42.8M | 4,803,447 | 6.5% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $37.9M | 1,731,365 | 5.8% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $30.2M | 790,000 | 4.6% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $28.0M | 1,075,000 | 4.3% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $22.3M | 1,440,999 | 3.4% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $21.9M | 2,824,029 | 3.3% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $18.0M | 853,884 | 2.7% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $17.8M | 495,823 | 2.7% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $17.7M | 2,025,000 | 2.7% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $15.2M | 1,835,000 | 2.3% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $14.7M | 1,204,958 | 2.2% |
| Arrowhead Pharmaceuticals in(ARWR) | COM | 04280A100 | $14.6M | 575,000 | 2.2% |
| Celcuity Inc(CELC) | COM | 15102K100 | $14.3M | 1,390,772 | 2.2% |
| Prometheus Biosciences Inc | COM | 74349U108 | $13.6M | 127,156 | 2.1% |
| Alpine Immune Sciences Inc(NVLSEUR) | COM | 02083G100 | $10.2M | 1,325,000 | 1.6% |
| DAY One Biopharmaceuticals I(DAWN) | COM | 23954D109 | $9.9M | 739,661 | 1.5% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $9.1M | 590,705 | 1.4% |
| Enanta Pharmaceuticals Inc(ENTA) | COM | 29251M106 | $8.8M | 217,253 | 1.3% |
| Allakos Inc(ALLKGUSD) | COM | 01671P100 | $8.5M | 1,900,000 | 1.3% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $7.5M | 200,000 | 1.1% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $5.1M | 635,000 | 0.8% |
| Third Harmonic BIO Inc(THRD) | COM | 88427A107 | $4.1M | 993,294 | 0.6% |
| Adverum Biotechnologies Inc(ADVMCHF) | COM | 00773U108 | $3.6M | 5,000,000 | 0.5% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $2.5M | 312,553 | 0.4% |
| Rezolute Inc(RZLT) | COM NEW | 76200L309 | $1.7M | 898,267 | 0.3% |
| Acumen Pharmaceuticals Inc(ABOS) | COM | 00509G209 | $1.6M | 400,000 | 0.2% |
| DBV Technologies S A | SPONSORED ADR | 23306J101 | $156.6K | 92,687 | 0.0% |